期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL DRUG INVESTIGATION LetPub Score 5.2
50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 7.0 | ||||||||||||||||
期刊簡稱 | CLIN DRUG INVEST | ||||||||||||||||
ISSN | 1173-2563 | ||||||||||||||||
E-ISSN | 1179-1918 | ||||||||||||||||
h-index | 53 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 3.40%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/40261 | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/cdia/ | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Springer International Publishing | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | NEW ZEALAND | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1989 | ||||||||||||||||
每年文章數 | 85每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 44.96% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-2563%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CLINICAL DRUG INVESTIGATION] 的評論 | 撰寫評論 |
作者: Renata Richardson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-04 08:02:02 評論於 It has been 2 weeks(0) 讚! | Renata Richardson |
作者: Renata Richardson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-29 21:45:34 評論於 It has been nine days(0) 讚! | Renata Richardson |
作者: 书生念凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-10 12:27:20 評論於 How much is the ad space fee? Or do we need to pay for the ad space?(0) 讚! | 书生念凡 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:51:51 評論於 Medicine, Scientific Reports, Plos One, Oncology Letter, Oncology Report, Cell Physiol Biochem, Biochemical and Biophysical Research, etc(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:19:26 評論於 Do not submit to newly emerging magazines with rapidly increasing impact factors; do not submit to journals with fewer publications; do not submit to journals from regions with less developed academia. Safe journals are those published by larger publishing groups or some high-impact factor magazines(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 16:04:28 評論於 Which journals are widely recognized as top-tier publications?(0) 讚! | 陶宜三岁啦 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 23:42:22 評論於 What pitfalls should be avoided when selecting publications?(0) 讚! | 破戒阳平 |
作者: 猫巷少女杉月 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 08:40:14 評論於 Do you accept submission processing fees? Thank you!(0) 讚! | 猫巷少女杉月 |
作者: 华清松雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-09-25 21:43:24 評論於 Editorial speed: 1.0 | Submission hit rate: 50.0 Experience sharing: I submitted my paper on July 19, 2016, and received major revisions on August 19. The revision period was originally one month, with over 60 review comments. However, the journal requested a submission within two weeks, so I had to rush to make revisions. I submitted the revised paper on the deadline of September 3, and fortunately it was accepted on September 8. Overall, the journal's efficiency is very high, and the opinions of the editors and reviewers are very fair and friendly. The attitude of the authors is also very important. My paper was about META of tumor drugs. Also, no page charges, no page charges!!!!!(0) 讚! | 华清松雨 |
作者: 努力啊大凡霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-06-13 21:13:47 評論於 Why can't I find the submission link for this magazine?(0) 讚! | 努力啊大凡霜 |
作者: 运峰酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-01-14 17:25:39 評論於 @wangwen414 How many days does it usually take for an Editor Assigned status? It's been eight days for me and there hasn't been any changes. Thanks(0) 讚! | 运峰酱大魔王 |
作者: 西域嘉庆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-01-12 20:34:51 評論於 My first SCI paper in my medical career was accepted today, and it was a meta-analysis. Overall, I feel that the journal is very efficient. I submitted it on October 24, 2015, and it was accepted on January 12, 2016. There was a major revision in between, and the editor-in-chief was very attentive, directly marking any grammar corrections on the revised PDF(0) 讚! | 西域嘉庆 |
作者: 运峰酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-01-12 18:20:11 評論於 @wangwen414 Hello, may I ask how long does it usually take for the magazine to assign an editor after submission? It's been 8 days since I submitted my article and the status is still "Editor Assigned". Why hasn't it changed yet? Thank you(0) 讚! | 运峰酱大魔王 |
作者: 运峰酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-12-15 23:00:34 評論於 @jocelyn624 Hello, I have an article I would like to submit to the magazine. Could you please provide the submission link? Thank you(0) 讚! | 运峰酱大魔王 |
作者: 博延公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-20 19:27:35 評論於 Review speed: 1.0 | Submission hit rate: 50.0 Experience sharing: It should be a copyright-free journal with relatively high efficiency. It took a total of one month and ten days from submission to acceptance. The journal favors clinical trials and meta-analysis. For meta-analysis, it is most important to measure scores and race against time. If others publish first, it will be left behind. Therefore, as long as you can accept risks, you can try high-scoring journals. I cannot accept risks, so I submitted to this journal. Overall, it is very nice. During major revisions, the editor directly edited the grammar in the submitted PDF, which touched me. It is the first time I have seen such a sincere editor after submitting so many journals(0) 讚! | 博延公子 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us